Figure 5.
The druggable grade III meningioma proteome. (a) Proteins with increased concordant expression in grade III vs. grade I meningiomas also associated with Food and Drug Administration (FDA)-approved drugs are displayed. (b) Top 20 concordantly expressed proteins based on average rank value and their associated FDA-approved drugs following submission to the drug–gene interaction database (DGIdb, v3.0). Table S6 provides details of transcripts/proteins associated with FDA-approved drugs.